Brief: Vera Therapeutics Q2 EPS USD -0.62 Vs. IBES Estimate USD -0.56
08/08/2024 13:00
Aug 08 (Reuters) - Vera Therapeutics Q2 operating income USD -37.343 million vs. IBES estimate USD -30.9 million. * Q2 net income USD -33.708 million vs. IBES estimate USD -29.6 million * Q2 operating expenses USD 37.343 million
Recent news on Vera Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Forgent Power, Vera Bradley, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Wells Fargo
U.S. STOCKS ON THE MOVE-Eli Lilly, Waystar, Sysco
Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial